Stock listing
Lang & Schwarz:A1XE7A Knight Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Knight Therapeutics, Inc. · home listing TSX:GUD
Follow Knight Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · TSX:GUD
$11.45 CAD +0.14 (+1.2%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSX:GUD
- Day range
- $11.26 – $11.54 CADOct 20, 2026
- Volume
- 48,255 sharesOct 20, 2026
- Market cap
- $1.12B CADAt the close on Oct 20, 2026 · price × 98.23M shares outstanding
- 52-week range
- $5.66 – $11.54 CADLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:GUD · Home | $11.45 CAD | +0.14 (+1.2%) | 48,255 | $11.34 | $11.54 | $11.26 | $11.31 | Close on Oct 20, 2026 |
| OTC:KHTRF | $7.94 USD | +0.23 (+3.0%) | 100 | $7.94 | $7.94 | $7.94 | $7.71 | Close on Oct 19, 2026 |
| Frankfurt:04K | €7.15 EUR | +0.20 (+2.9%) | — | €7.15 | €7.15 | €7.15 | €6.95 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · TSX:GUD · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.45 | +0.14 | +1.2% | $11.34 | $11.54 | $11.26 | 48,255 | |
| $11.31 | +0.27 | +2.4% | $11.10 | $11.35 | $11.10 | 93,448 | |
| $11.04 | +0.24 | +2.2% | $10.85 | $11.16 | $10.83 | 81,531 | |
| $10.80 | +0.19 | +1.8% | $10.79 | $10.80 | $10.58 | 47,800 | |
| $10.61 | -0.07 | -0.7% | $10.65 | $10.73 | $10.59 | 67,000 | |
| $10.68 | -0.15 | -1.4% | $10.84 | $10.84 | $10.65 | 93,700 | |
| $10.83 | +0.10 | +0.9% | $10.66 | $11.00 | $10.40 | 76,800 | |
| $10.73 | +0.02 | +0.2% | $10.73 | $10.82 | $10.64 | 49,200 | |
| $10.71 | +0.17 | +1.6% | $10.31 | $10.79 | $10.31 | 61,400 | |
| $10.54 | +0.18 | +1.7% | $10.41 | $10.57 | $10.37 | 68,200 | |
| $10.36 | +0.04 | +0.4% | $10.34 | $10.36 | $10.21 | 64,300 | |
| $10.32 | -0.32 | -3.0% | $10.67 | $10.80 | $10.31 | 63,800 | |
| $10.64 | +0.05 | +0.5% | $10.60 | $10.64 | $10.47 | 56,200 | |
| $10.59 | +0.24 | +2.3% | $10.35 | $10.74 | $10.28 | 118,800 | |
| $10.35 | +0.08 | +0.8% | $10.20 | $10.41 | $10.16 | 53,800 | |
| $10.27 | -0.02 | -0.2% | $10.24 | $10.30 | $10.18 | 34,500 | |
| $10.29 | +0.19 | +1.9% | $10.24 | $10.29 | $10.10 | 60,900 | |
| $10.10 | +0.01 | +0.1% | $10.04 | $10.17 | $10.01 | 57,600 | |
| $10.09 | -0.20 | -1.9% | $10.29 | $10.29 | $10.01 | 80,200 | |
| $10.29 | +0.11 | +1.1% | $10.24 | $10.37 | $10.18 | 137,400 | |
| $10.18 | -0.07 | -0.7% | $10.26 | $10.26 | $10.15 | 63,300 | |
| $10.25 | +0.02 | +0.2% | $10.25 | $10.27 | $10.10 | 59,700 | |
| $10.23 | +0.22 | +2.2% | $10.07 | $10.34 | $10.06 | 57,600 | |
| $10.01 | +0.05 | +0.5% | $9.99 | $10.15 | $9.86 | 74,400 | |
| $9.96 | -0.06 | -0.6% | $9.97 | $10.11 | $9.89 | 45,300 | |
| $10.02 | +0.17 | +1.7% | $9.89 | $10.09 | $9.85 | 57,000 | |
| $9.85 | +0.12 | +1.2% | $9.75 | $9.86 | $9.74 | 197,500 | |
| $9.73 | -0.17 | -1.7% | $9.88 | $9.93 | $9.65 | 82,000 | |
| $9.90 | 0.00 | 0.0% | $9.88 | $9.94 | $9.86 | 42,200 | |
| $9.90 | -0.11 | -1.1% | $9.90 | $9.94 | $9.80 | 40,400 | |
| $10.01 | -0.03 | -0.3% | $9.95 | $10.05 | $9.85 | 44,900 | |
| $10.04 | +0.37 | +3.8% | $9.60 | $10.10 | $9.58 | 488,500 | |
| $9.67 | +0.03 | +0.3% | $9.65 | $9.97 | $9.61 | 86,300 | |
| $9.64 | -0.02 | -0.2% | $9.60 | $9.70 | $9.56 | 35,800 | |
| $9.66 | +0.19 | +2.0% | $9.50 | $9.70 | $9.48 | 55,800 | |
| $9.47 | -0.12 | -1.3% | $9.60 | $9.61 | $9.47 | 39,900 | |
| $9.59 | -0.17 | -1.7% | $9.33 | $9.76 | $9.33 | 35,900 | |
| $9.76 | +0.01 | +0.1% | $9.47 | $9.80 | $9.47 | 42,400 | |
| $9.75 | +0.09 | +0.9% | $9.67 | $9.91 | $9.67 | 82,018 | |
| $9.66 | 0.00 | 0.0% | $9.66 | $9.83 | $9.38 | 91,321 | |
| $9.66 | +0.03 | +0.3% | $9.70 | $9.74 | $9.61 | 39,100 | |
| $9.63 | -0.19 | -1.9% | $9.84 | $9.93 | $9.63 | 53,600 | |
| $9.82 | +0.09 | +0.9% | $9.73 | $9.89 | $9.69 | 55,000 | |
| $9.73 | -0.05 | -0.5% | $9.75 | $9.80 | $9.61 | 53,300 | |
| $9.78 | +0.46 | +4.9% | $9.34 | $9.80 | $9.30 | 96,100 | |
| $9.32 | +0.11 | +1.2% | $9.21 | $9.32 | $9.20 | 122,200 | |
| $9.21 | -0.08 | -0.9% | $9.34 | $9.34 | $9.20 | 51,800 | |
| $9.29 | -0.21 | -2.2% | $9.50 | $9.65 | $9.24 | 120,700 | |
| $9.50 | +0.19 | +2.0% | $9.41 | $9.60 | $9.41 | 85,929 | |
| $9.31 | -0.45 | -4.6% | $9.62 | $9.82 | $9.31 | 68,423 | |
| $9.76 | +0.26 | +2.7% | $9.50 | $9.85 | $9.48 | 249,900 | |
| $9.50 | +0.24 | +2.6% | $9.52 | $10.00 | $9.20 | 222,400 | |
| $9.26 | -0.08 | -0.9% | $9.34 | $9.36 | $9.22 | 183,800 | |
| $9.34 | -0.50 | -5.1% | $9.84 | $9.85 | $9.31 | 107,400 | |
| $9.84 | +0.07 | +0.7% | $9.59 | $9.93 | $9.59 | 60,300 | |
| $9.77 | -0.10 | -1.0% | $9.80 | $9.95 | $9.72 | 59,600 | |
| $9.87 | +0.03 | +0.3% | $9.84 | $10.00 | $9.77 | 50,100 | |
| $9.84 | +0.02 | +0.2% | $9.83 | $9.88 | $9.78 | 58,700 | |
| $9.82 | +0.09 | +0.9% | $9.72 | $9.87 | $9.72 | 52,000 | |
| $9.73 | +0.04 | +0.4% | $9.68 | $9.80 | $9.68 | 34,000 | |
| $9.69 | +0.01 | +0.1% | $9.75 | $9.76 | $9.67 | 67,000 | |
| $9.68 | -0.29 | -2.9% | $9.98 | $10.05 | $9.65 | 131,500 | |
| $9.97 | +0.13 | +1.3% | $9.85 | $10.01 | $9.84 | 78,881 | |
| $9.84 | +0.02 | +0.2% | $9.80 | $9.89 | $9.77 | 26,679 |
- Ticker
- Lang & Schwarz:A1XE7A
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 6, 2026
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
Latest earnings call · Aug 6, 2026
Knight Therapeutics (TSX:GUD) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 21 slides
Calls
Replays
Knight Therapeutics (TSX:GUD) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:30 AM ET
Watch TranscriptKnight Therapeutics (TSX:GUD) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptKnight Therapeutics (TSX:GUD) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
Oct 6, 2026
Closed $10.54 (+1.7%) on Oct 6, 2026
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
Oct 6, 2026
Closed $10.54 (+1.7%) on Oct 6, 2026
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America
Sep 29, 2026
Closed $10.35 (+0.8%) on Sep 29, 2026
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
Sep 29, 2026
Closed $10.35 (+0.8%) on Sep 29, 2026
Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada's Top Growing Companies
Sep 25, 2026
Closed $10.29 (+1.9%) on Sep 25, 2026
Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada
Sep 15, 2026
Closed $9.96 (-0.6%) on Sep 15, 2026
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia
Sep 1, 2026
Closed $9.67 (+0.3%) on Sep 2, 2026
Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil
Aug 27, 2026
Closed $9.47 (-1.3%) on Aug 28, 2026
Knight Therapeutics Announces Launch of WYNZORA® in Canada
Aug 20, 2026
Closed $9.63 (-1.9%) on Aug 20, 2026
Knight Therapeutics Reports Second Quarter 2026 Results
Aug 6, 2026
Closed $9.50 (+2.6%) on Aug 6, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 21 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · May 7, 2026
Q2 2025 Earnings Presentation
Earnings · 21 slides · Aug 7, 2025
Investor Presentation (October 2024)
Investor deck · 20 slides · October 2024
Knight Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 39 in the last 12 months · 80 in all · newest Oct 6, 2026 · oldest 2016
- Calls
- 18 calls with a replay · 18 with a transcript · latest Aug 6, 2026
- Decks
- 10 decks · latest August 2026
Where Knight Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:GUD · Home listing | TSX | Canada | CAD |
| OTC:KHTRF | OTC | United States | USD |
| Cboe Canada:GUD | Cboe Canada | Canada | CAD |
| LS Exchange:A1XE7A | LS Exchange | Germany | EUR |
| gettex:04K | gettex | Germany | EUR |
| Frankfurt:04K | Frankfurt | Germany | EUR |
| Dusseldorf:04K | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A1XE7A · This page | Lang & Schwarz | Germany | EUR |
| Munich:04K | Munich | Germany | EUR |
| Stuttgart:04K | Stuttgart | Germany | EUR |
| Tradegate:04K | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Knight Therapeutics, Inc.